Rocket Pharmaceuticals (RCKT) Treasury Shares (2016 - 2026)

Rocket Pharmaceuticals has disclosed Treasury Shares across 5 years of filings, most recently posting $47000.0 for Q2 2023.

• Treasury Shares for Q2 2023 came in at $47000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $47000.0 (changed N/A YoY), and the FY2022 annual result was $47000.0, changed N/A from the prior year.
• Treasury Shares came in at $47000.0 for Q2 2023 at Rocket Pharmaceuticals, roughly flat from $47000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $7.7 million in Q1 2026 to a low of $2571.0 in Q1 2023.
• The 5-year median for Treasury Shares is $1.6 million (2024), against an average of $2.7 million.
• Across the five-year window, Treasury Shares plunged 92.07% in 2019 and slumped 77.91% in 2020, its largest moves.
• Rocket Pharmaceuticals' Treasury Shares stood at $53000.0 in 2019, then jumped by 43.4% to $76000.0 in 2020, then slumped by 38.16% to $47000.0 in 2022, then changed by 0.0% to $47000.0 in 2023.
• The last three Treasury Shares figures came in at $47000.0 (Q2 2023), $47000.0 (Q1 2023), and $47000.0 (Q4 2022), per Business Quant data.